ClinicalTrials.gg

Jiangsu Aosaikang Pharmaceutical Co., Ltd. clinical trials

A subsidiary of Beijing Aosaikang Pharmaceutical Co., Ltd.

The registry lists 14 studies whose lead sponsor is Jiangsu Aosaikang Pharmaceutical Co., Ltd.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2026.

What it is testing

The drugs Jiangsu Aosaikang Pharmaceutical Co., Ltd.’s studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Jiangsu Aosaikang Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 2O
  13. N

Add all 3 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 17, 2026.

All 14 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now643%Not yet recruiting 3 · Recruiting 3
  • Under way, not recruiting321%
  • Completed321%
  • Status unknown or other214%

Phase

  • Phase 18
  • Phase 24
  • Phase 34

Where

Over the years

  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 22
  7. 23
  8. 24
  9. 25
  10. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.14 studies

Something wrong with this grouping? Tell us on the Beijing Aosaikang Pharmaceutical Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 14 of 14. All Beijing Aosaikang Pharmaceutical Co., Ltd. studies →